CMIC Ashfield Co., Ltd. (Headquarters: Shibaura, Minato-ku, Tokyo, Representative Directors: Hisao Matsubara, Martin Miguel) announces that it will change its company name to "CMIC Inizio Co., Ltd." effective October 1.

Effective Date: October 1, 2023
New Company Name: CMIC Inizio Co., Ltd 

Reason for Change
We are a joint venture between CMIC HOLDINGS Co., Ltd., which provides comprehensive  operational support from pharmaceutical development and manufacturing to sales and marketing, and UDG Healthcare Plc., with its Ashfield Group, which helps build engagement between companies involved in pharmaceuticals and healthcare professionals and patients globally. 

Clayton Dubilier & Rice ("CD&R"), a US-based private equity firm, acquired UDG in 2021, and the business units owned by CD&R and the ones operated by Ashfield were reorganized and merged under the comprehensive brand "Inizio" in 2022.

Inizio's engagement business unit was rebranded to “Inizio Engage” effective June 6, 2023, and our company will change its name to the new company name effective October 1, 2023, when the new fiscal year will begin.

Impact of Change
The name change to Inizio Engage and CMIC Inizio will not have any material impacts on our existing client contracts or service offerings in the Japanese market. There will be no change in the capital ratio or management structure as a result of the company name change.
We have been leveraging the expertise of our parent company, which offers advanced solutions on a global scale, for our domestic business. We expect that this opportunity will expand our service portfolio to meet the challenges of domestic pharmaceutical and other companies, whose industries have been getting more sophisticated and complex.

Leveraging our knowledge in the healthcare domain in Japan and our parent company's strength in developing diverse services for the global market, we will continuously deliver better healthcare through our variety of services that support communication between pharmaceutical, life science and healthcare companies, healthcare professionals, and the medical field.

■About Inizio



Inizio unlocks the value of healthcare innovations by connecting best-in-class strategic, analytic, and creative capabilities. Bridging scientific knowledge, market intelligence, actionable data, cutting-edge tech and creative execution, Inizio helps its clients navigate the complex lifecycle of their assets and achieve optimal outcomes at every pivotal moment on its journey to patients.

Inizio has five specialist business units, each comprising best-in-class companies that provide the depth, breadth, and scale to activate transformational change and reimagine health.
Inizio is backed by Clayton, Dubilier & Rice (CD&R).

For more information visit: www.inizio.health

■About Inizio Engage
 


Part of the Inizio Group, Inizio Engage is a strategic, commercial, and creative engagement partner that specializes in healthcare. Our passionate, global workforce provides bespoke engagement solutions via a unique combination of consultation, creation, and activation expertise. We augment our local expertise and a diverse mix of skills with data, science, and technology, to challenge convention and deliver experiences that create lasting change. It’s how we’re reimagining the way our clients engage patients, payers, people, and providers to enhance treatment outcomes and improve lives.

Specialist areas: 

• Decision Optimization - brings together expertise in data and integrated insights, treatment experience design, independent industry benchmarking and market access. All combine unique methodologies, advanced analytics, and deep expertise to ensure clients' engagement strategies become their best source of competitive advantage.
• XD (Experience Design) - combines insight, expertise, and creative to design and deliver world class experiences that engage people, change mindsets and behavior, enrich cultures, enhance skills, and drive overall business performance.
• Patient Solutions - harnesses the power of empathy and insights to enhance access and adherence, delivering patient-centric engagement solutions built upon a strong culture and heritage, a wide range of capabilities, deep expertise, and partnership.  
• Medical Affairs - provides vital medical information and compelling scientific dialogue to meet regulatory requirements, achieve business objectives, and enhance the customer experience.
•  Commercial - combines the latest technology and data-driven insights with motivated teams to create innovative omnichannel solutions designed to accelerate sales performance and maximize commercial success.

For information visit: www.inizioengage.com